mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.8 |